RORA Biologics - Crunchbase Company Profile & Funding

Overview

RORA Biologics

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About RORA Biologics

CB Rank

461272

RORA Biologics develops T-cell platforms for cancer and infectious disease treatments.

Founded

obfuscation

Private

Atlanta, Georgia, United States

1-10

www.rorabio.com

Analytics

Biopharma

Biotechnology

Key People

Randy Berholtz: Co-Founder and Chairman
Past Role: Rancho Santa Fe Bio, CEO and Co-Founder

Details

Legal Name

RORA Biologics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Randy Berholtz

About the Company

RORA Biologics focuses on biotechnology research, specifically developing a T-cell platform aimed at treating cancer and infectious diseases. The company holds an exclusive license agreement with Case Western Reserve University for intellectual property related to this technology.

Contact Email

contact@rorabio.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

RORA-Tscm Platform

A T-cell platform based on a newly discovered, long-lived, stem-like memory T-cell population used to develop cell therapies for cancer and infectious diseases.

Bispecific anti-BCMA-CS1 CAR-Tscm Cell Therapy

A CAR-T cell therapy using RORA-Tscm cells engineered with a bispecific receptor targeting BCMA and CS1 antigens on multiple myeloma cells to treat relapsed and refractory multiple myeloma.